10/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

10/2023

Oct 3, 2023, 18:07 | Blog
Guilherme Perini: Would love to hear colleagues from Low- or Middle-Income Countries.
Guilherme Perini, Hematologist at Israelita Albert Einstein Hospital, shared a post by Bishal Gyawali on…
Oct 3, 2023, 18:02 | Insight
Vivek Subbiah: Delighted to publish our editorial. TRKing sarcomas for precision medicine: Seek, and ye shall find! In the American Cancer Society Journal Cancer.
Vivek Subbiah, Chief of Early-Phase Drug Development at the  Sarah Cannon Research Institute, shared on X/Twitter:…
Oct 3, 2023, 17:56 | Career
Wafik S. El-Deiry: Congratulations to Joann Sweasy on her new role.
Quoting Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Brown…
Oct 3, 2023, 17:55 | Insight
We asked Chatgpt to identify nuclei larger than 15 microns in diameter! Not bad, isn't it! - Journal of Clinical Pathology
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology, and Scientific Director of the Sheikh…
Oct 3, 2023, 17:49 | Career
Wee Joo Chng: Very proud of my PhD Student Mun Yee Koh who won the young investigator award at the recently concluded International Myeloma Society Annual Meeting.
Quoting Wee Joo Chng, Vice President of BioMedical Sciences Research at The National University of…
Oct 3, 2023, 17:43 | Drugs,Insight
Rafael Fonseca: The clinical development curse against venetoclax for t(11;14) multiple myeloma.
Rafael Fonseca, the Chief Innovation Officer at Mayo Clinic, Arizona, recently tweeted on X/Twitter: ''The…
Oct 3, 2023, 17:37 | Blog
Vania Wisdom: After the launch of  The Lancet Commission on Women, power and cancer, I am still feeling the inspiration and energy of this group!
Quoting Vania Wisdom, Executive editor and oncology ambassador at The Lancet, on LinkedIn: ''After the…
Oct 3, 2023, 17:31 | Blog
Allison Rosenzweig: Dave Tuveson got a PanCAN CDA in 2003 - our 1st year awarding grants.
Quoting Allison Rosenzweig, Director of Scientific Comms for the Pancreatic Cancer Action Network, on X/Twitter:…
Oct 3, 2023, 17:22 | Insight
William Oh: For men with aggressive prostate cancer, genetic testing can inform treatment decisions.
Quoting William Oh, Chief Medical Officer of Prostate Cancer Foundation, on LinkedIn: ''Germline exome sequencing…
Oct 3, 2023, 17:19 | Drugs
Talha Badar: The story of Luspatercept!
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, recently tweeted: ''Weekend…
All: 805 Posts: 741 - 750